Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Longboard Pharmaceuticals in a research report issued to clients and investors on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn ($2.11) per share for the year. The […]